Nirvana Life Sciences Inc. (CSE:NIRV.X)
Canada · Delayed Price · Currency is CAD 0.0100
-0.0300 (-75.00%)
At close: Apr 23, 2026
-90.48% (1Y)
| Market Cap | 229.23K -97.2% |
| Revenue (ttm) | n/a |
| Net Income | -358.63K |
| EPS | -0.02 |
| Shares Out | 22.92M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 8,000 |
| Average Volume | 5,783 |
| Open | 0.0450 |
| Previous Close | 0.0400 |
| Day's Range | 0.0050 - 0.0450 |
| 52-Week Range | 0.0050 - 0.1400 |
| Beta | -0.57 |
| RSI | 41.64 |
| Earnings Date | Sep 8, 2026 |